The trademark application Fianzadec was filed by Novo Nordisk A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on February 27, 2012, and it was registered by office on June 5, 2012 without any oppositions.
The application was filed in Danish (English was selected as the second language).
The renewal of the trademark was recorded by the office on November 25, 2022.
of the trademark registration was recorded on November 25, 2022.